Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Non-adherence should be addressed first
| The first 150 words of the full text of this article appear below. |
EDITOR
Nuesch et al showed in their study that electronic monitoring of
patient's adherence had no significant effect on ambulatory blood
pressure.1 Because non-adherence was not more prevalent among patients with resistance to antihypertensive treatment, they
concluded that other factors independent of a patient's willingness to
adhere are more relevant in explaining failure of treatment in most
patients. These results should, however, be interpreted with caution
because of possible selection and differential measurement bias that
may have occurred in the study.
Patients who accepted inclusion in the study and were therefore
monitored for blood pressure and adherence may adhere more to
antihypertensive treatments than the general population. We have no
information about how many eligible patients refused to participate.
Furthermore, after 28 days of study and on the basis of the results of
ambulatory blood pressure, more patients became responsive to treatment
than became non-responsive (
2=2.9, P<0.09)
14/49
(28.6%)